INVO Bioscience, Inc. (IVOB) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 287 transactions totaling $27.4M, demonstrating a bearish sentiment with -$27.4M in net insider flow. The most recent transaction on Jan 17, 2020 involved a transaction of 1,000,000 shares valued at $0.
No significant insider buying has been recorded for IVOB in the recent period.
No significant insider selling has been recorded for IVOB in the recent period.
Based on recent SEC filings, insider sentiment for IVOB is bearish with an Insider Alignment Score of 0/100 and a net flow of -$27.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at INVO Bioscience, Inc. (IVOB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading IVOB stock, having executed 287 transactions in the past 90 days. The most active insider is Claude Ranoux (Executive), who has made 261 transactions totaling $28.7M.
Get notified when executives and directors at IVOB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 17, 2020 | Jos. Campbell Michael | Executive | Award | 1,000,000 | $N/A | $0 | |
| Oct 16, 2019 | Shum Steve | Executive | Award | 400,000 | $N/A | $0 | |
| Dec 3, 2018 | Ranoux Claude | Executive | Discretionary | 1,000,000 | $N/A | $0 | |
| Dec 3, 2018 | Ranoux Claude | Executive | Sale | 500,000 | $0.05 | $25.0K | |
| Dec 3, 2018 | Ranoux Claude | Executive | Discretionary | 1,000,000 | $N/A | $0 | |
| Dec 3, 2018 | Ranoux Claude | Executive | Sale | 500,000 | $0.05 | $25.0K | |
| Oct 31, 2018 | Ranoux Claude | Executive | Award | 910,878 | $N/A | $0 | |
| Oct 31, 2018 | Ranoux Claude | Executive | Award | 910,878 | $0.39 | $355.2K | |
| Oct 31, 2018 | Joseph Bowdring Robert Jr | Executive | Award | 1,015,942 | $0.39 | $396.2K | |
| Oct 31, 2018 | Jos. Campbell Michael | Executive | Award | 400,000 | $0.39 | $156.0K | |
| Oct 31, 2018 | T. Karloff Kathleen | Executive | Award | 1,040,183 | $0.39 | $405.7K | |
| Oct 31, 2018 | Shum Steve | Executive | Award | 400,000 | $0.39 | $156.0K | |
| Mar 5, 2018 | Ranoux Claude | Executive | Sale | 12,642 | $0.19 | $2.4K | |
| Mar 5, 2018 | Ranoux Claude | Executive | Sale | 12,642 | $0.19 | $2.4K | |
| Feb 28, 2018 | Ranoux Claude | Executive | Sale | 2,000 | $0.18 | $360 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 103 | $27.4M | 86.8% |
Award(A) | 28 | $3.4M | 10.9% |
Disposition(D) | 152 | $728.2K | 2.3% |
Discretionary(I) | 3 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at INVO Bioscience, Inc. has increased, with 5 insiders executing 287 transactions across all time. Total sales of $27.4M significantly outpace purchases of $0, resulting in a net outflow of $27.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.